PRONULIFE®RenaProtect-Kidney Health Probiotics
Product description
Glac's R&D Center conducted multiple tests confirming PRONULIFE® RenaProtect probiotics: Lactobacillus acidophilus TYCA06, Bifidobacterium longum subsp. infantis BLI-02, and Bifidobacterium bifidum VDD088. These probiotics safeguard kidneys by reducing toxin (indole) production, alleviating kidney inflammation and fibrosis, improving indicators like hypertension and body weight caused by chronic kidney disease (CKD) in mice. Clinical studies show the strain combination delays kidney function deterioration and reduces inflammation. NGS analysis validates genuine changes in gut microbiota, effectively improving gastrointestinal discomfort caused by prolonged medication.→See more: https://lihi.cc/TCIrQ/IIN_LvUcare
Read more
Specifications
Categories | Clinical trials; Contract manufacturing; Probiotics |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America |
Supplied from | Taiwan, China |
Product Applications | Food Supplements; Natural Products |
Product Certifications | Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Sustainable; Traceable |
PRONULIFE®RenaProtect-Kidney Health Probiotics